Two die in Japan after shots from suspended Moderna vaccines

A signboard is displayed during a Moderna covid-19 coronavirus vaccination campaign at the Tokyo Metropolitan Government building in Tokyo on June 25, 2021. Rodrigo Reyes Marin / POOL / AFP

Two people died after receiving Moderna COVID-19 vaccine shots that were among lots later suspended following the discovery of contaminants, Japan's health ministry said on Saturday.

The men in their 30s died this month within days of receiving their second Moderna doses, the ministry said in a release. Each had a shot from one of three manufacturing lots suspended on Thursday. The cause of the deaths is still being investigated.

Japan halted the use of 1.63 million Moderna doses shipped to 863 vaccination centres nationwide, more than a week after the domestic distributor, Takeda Pharmaceutical, received reports of contaminants in some vials.

"At this time, we do not have any evidence that these deaths are caused by the Moderna COVID-19 vaccine," Moderna and Takeda said in a statement on Saturday. "It is important to conduct a formal investigation to determine whether there is any connection."

The government has also said no safety or efficacy issues had been identified and the suspension of the three Moderna batches was a precaution.

Fumie Sakamoto, the infection control manager at St. Luke's International Hospital in Tokyo, cautioned against drawing a connection between the shots and the fatalities reported on Saturday.

"There may only be a temporal relationship between vaccination and death," Sakamoto told Reuters. "There are so many things we still don't know to make any conclusions on these two cases."

The contaminants found in some vials in Japan are believed to be metallic particles, public broadcaster NHK reported, citing health ministry sources.

Japan has administered more than 124 million COVID-19 vaccine shots, with about 44% of the population fully inoculated.

As of Aug. 8, 991 people had died in Japan after receiving shots of Pfizer Inc's vaccine and 11 after receiving Moderna's, but no causality between the injections and the deaths has been established, according to the health ministry. Adverse reactions have been reported at a frequency of 0.01% for the Moderna shot.

In the fatalities reported on Saturday, each man had a fever the day after his second dose and died two days after getting the fever. There has been no evidence that their shots contained contaminants, a health ministry official told reporters.

More from International

  • Afghanistan says Pakistan strikes kill and injure dozens

    Pakistan said it launched strikes on targets in Afghanistan after blaming recent suicide bombings, including assaults during the holy month of Ramadan, on fighters it said were operating from its neighbour's territory.

  • Police officer killed, dozens injured in bomb explosions in Ukraine's Lviv

    One police officer was killed and 24 other people were injured after several explosive devices detonated at midnight in Lviv in western Ukraine, the National Police said on Sunday.

  • Trump pivots to new 15% global tariff after Supreme Court setback

    President Donald Trump said on Saturday he will raise a temporary tariff from 10 per cent to 15 per cent on US imports from all countries, the maximum level allowed under the law, after the US Supreme Court struck down his previous tariff programme. The move came less than 24 hours after Trump announced a 10% across-the-board tariff on Friday after the court's decision. The ruling found the president had exceeded his authority when he imposed an array of higher rates under an economic emergency law. The new levies are grounded in a separate but untested law, known as Section 122, that al

  • Hong Kong plans to buy homes devastated in deadly high-rise fire

    Hong Kong proposes to spend about HK$4 billion ($512 million) to buy out the owners of homes in a high-rise housing complex ravaged by a massive fire to resettle nearly 2,000 affected households.

  • US Supreme Court strikes down Trump's global tariffs

    The US Supreme Court struck down Donald Trump's sweeping tariffs that he pursued under a law meant for use in national emergencies, handing a stinging defeat to the Republican president in a landmark opinion on Friday with major implications for the global economy.